Immune to Cancer: The CRI Blog
-
Supercharging T Cells to Fight Cancer: A Revolutionary Discovery
In the battle against cancer, our immune system’s T cells are frontline soldiers, designed to seek out… -
Key Discoveries from the AMADEUS Clinical Trial on Cancer Treatment
The Cancer Research Institute (CRI) is excited to share the findings from the AMADEUS clinical trial, which… -
Can Table Salt Supercharge Your Immune System to Fight Cancer?
The Cancer Research Institute (CRI) is excited to share the latest study from CRI Lloyd J. Old… -
How Focused Ultrasound and Immunotherapy Could Transform Cancer Treatment
Recent advancements in cancer treatment are reshaping patient care in multiple ways. Focused ultrasound and cancer immunotherapy… -
How Proteasomes are Changing the Face of Cancer Immunotherapy
Cancer immunotherapy is revolutionizing treatment by harnessing the power of the body’s own immune system to recognize,… -
FDA approves EPKINLY® for relapsed or refractory follicular lymphoma
June 26, 2024, marked a milestone for patients suffering from follicular lymphoma. The FDA approved Genmab’s epcoritamab-bysp… -
CRI’s 5th Annual Wear White Luncheon Raises Over $40,000
On Thursday, June 20, 2024, the Cancer Research Institute (CRI) celebrated its fifth annual Wear White Luncheon,… -
Keytruda Receives 40th FDA Approval
This week marked a significant milestone in the fight against cancer. On June 17, the FDA approved… -
New Insights on CAR-T Design: Paving the Way for Broader Cancer Applications
The Cancer Research Institute (CRI) is excited to share the latest study from CRI Lloyd J. Old…